Radiant Innovation

Radiant Innovation EPS Growth

The EPS Growth of Radiant Innovation (3373.TWO) as of Nov 20, 2026 is -111.53 %. In the previous year, EPS Growth was 41.40 % — a change of -369.39% (lower).

EPS Growth

-111.53 %

YoY

-369.39%

Last updated:

EPS Growth of Radiant Innovation is 2025 -111.53 % . EPS Growth of Radiant Innovation was 2024 41.40 % . It decreases by -369.39% lower compared to the previous year.

The Radiant Innovation EPS Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS Growth
Date
EPS Growth
Jan 1, 2018
7.11 TWD
Jan 1, 2019
102.15 TWD
Jan 1, 2020
2,459.79 TWD
Jan 1, 2021
-84.73 TWD
Jan 1, 2022
-74.51 TWD
Jan 1, 2023
-270.13 TWD
Jan 1, 2024
41.40 TWD
Jan 1, 2025
-111.53 TWD
The Radiant Innovation EPS Growth history
YEAREPS GrowthYoY
-111.53 %-369.39%
41.40 %-115.33%
-270.13 %+262.52%
-74.51 %-12.05%
-84.73 %-103.44%
2,459.79 %+2,308.01%
102.15 %+1,336.05%
7.11 %-111.93%
-59.62 %+25.29%
-47.59 %-180.19%
59.34 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Radiant Innovation Stock analysis

What does Radiant Innovation do? Radiant Innovation Inc. generates revenue through the design, manufacture, and sale of infrared technology products. The company's main products include infrared temperature measurement instruments, ear temperature guns, frontal temperature guns, and other body temperature measurement products, alongside carbon dioxide detectors, infrared thermal imagers, and blood glucose dedicated chipsets. These products are distributed domestically and internationally across Asia, the Americas, Europe, and other regions. The primary buyers are healthcare providers, medical facilities, and electronic component distributors who require precise measurement tools and specialized components for health monitoring and diagnostics. The firm's product portfolio targets healthcare and industrial segments, with infrared thermal imagers used in building inspections and carbon dioxide detectors deployed in environmental monitoring. Blood glucose dedicated chipsets are supplied to medical device manufacturers for integration into diagnostic equipment. International distribution channels focus on regions like Asia, the Americas, and Europe, where demand for health-related measurement devices remains strong. Revenue streams are driven by direct sales to medical institutions, electronic component distributors, and industrial clients. The company's product lines serve both consumer-facing health monitoring applications and specialized industrial uses, with a strong emphasis on accuracy and reliability in temperature and gas detection technologies. Radiant Innovation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Radiant Innovation stock

EPS Growth of Radiant Innovation is -111.53 % in 2025.

On Eulerpool you can find the complete historical development of EPS Growth Radiant Innovation since 2006 – with annual values, charts, and detailed analysis.

EPS growth measures the percentage change in earnings per share. It accounts for both profit changes and share count changes.

To evaluate EPS Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EPS Growth.

EPS Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EPS Growth's Radiant Innovation historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Radiant Innovation

All Key Metrics — Radiant Innovation